Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

734 Articles

Jon C. Ogg | Dec 10, 2013 at 4:04 PM EST

Big Insider Selling at Gilead

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has been on fire, so much that two insiders decided to stuff their holiday stockings…

Jon C. Ogg | Nov 22, 2013 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Gilead, Gogo, Micron, Target, Windstream and More

ThinkstockThe DJIA has finally closed above 16,000 for the first time ever. With a light holiday week coming up and…

Jon C. Ogg | Nov 21, 2013 at 7:25 AM EST

Solid Biotech Stocks With the Best Revenue Growth for 2014

ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up…

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Lee Jackson | Nov 5, 2013 at 8:15 AM EST

UBS Adds Six Top Alpha Preference List Stocks to Buy for 2014

The Alpha Preference list of stocks to buy at UBS is comprised of companies that are the most preferred stocks…

Jon C. Ogg | Nov 2, 2013 at 7:15 AM EDT

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%.…

Jon C. Ogg | Nov 1, 2013 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Facebook, Netflix, PetSmart, Valero and More

Jon OggWe are nearing the end of earnings season, and stocks have challenged new all-time highs. Now investors are starting…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

Lee Jackson | Oct 3, 2013 at 11:50 AM EDT

Top Biotechs Set to Win in the War on Cancer

ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Jul 31, 2013 at 8:35 AM EDT

UBS Updates and Adds Top Stocks to the Alpha Preference List

ThinkstockAlpha is one of those confusing terms that is used in the financial industry but rarely defined. It is basically…

Trey Thoelcke | Jul 3, 2013 at 8:10 AM EDT

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

When we screen stocks at the Wall Street firms we cover, we always are anxious to provide our readers with…

Jon C. Ogg | Jun 13, 2013 at 8:15 AM EDT

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale…

Jon C. Ogg | May 15, 2013 at 8:10 AM EDT

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and…

1 … 39 40 41 42 43 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Big Insider Selling at Gilead

Top Analyst Upgrades and Downgrades: Gilead, Gogo, Micron, Target, Windstream and More

Solid Biotech Stocks With the Best Revenue Growth for 2014

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

UBS Adds Six Top Alpha Preference List Stocks to Buy for 2014

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Top Analyst Upgrades and Downgrades: Facebook, Netflix, PetSmart, Valero and More

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

UBS Updates and Adds Top Stocks to the Alpha Preference List

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Deutsche Bank Firm on Biotech Stocks to Buy

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Gilead Sciences : GILD

All Gilead Sciences Articles

Big Insider Selling at Gilead

Top Analyst Upgrades and Downgrades: Gilead, Gogo, Micron, Target, Windstream and More

Solid Biotech Stocks With the Best Revenue Growth for 2014

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

UBS Adds Six Top Alpha Preference List Stocks to Buy for 2014

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Top Analyst Upgrades and Downgrades: Facebook, Netflix, PetSmart, Valero and More

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

UBS Updates and Adds Top Stocks to the Alpha Preference List

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Deutsche Bank Firm on Biotech Stocks to Buy

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

Featured Reads

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check